In a phase 3, double-blind, randomized, controlled trial, 2,539 adults with a body-mass index (BMI) of 30 or greater, or 27 or greater with at least one weight-related complication, were given weekly subcutaneous injections of tirzepatide (5 mg, 10 mg, or 15 mg) or a placebo for 72 weeks
Marci R, Mallozzi M, Di Benedetto L, et al
4 This includes 4.45 times more than the average price paid in France, 3.85 times more than the average price paid in the United Kingdom, and 3.24 times the average price paid in Canada
What Happens to Insulin Levels if You Stop Taking a GLP-1 for Type 2 Diabetes Treatment
In: Kaneko JJ (ed) Clinical biochemistry of domestic animals, third edn